NeuBase Therapeutics, Inc. (NBSE) Financials
NBSE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 18.6 million | 9.5 million |
2023-06-30 | 22.3 million | 11.1 million |
2023-03-31 | 21.5 million | 7.0 million |
2022-12-31 | 25.6 million | 7.4 million |
NBSE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.0 million | -292343 |
2023-06-30 | -3.6 million | 245012 |
2023-03-31 | -3.5 million | 316689 |
2022-12-31 | -5.7 million | -509072 |
NBSE Net Income
No data available :(
NBSE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 12.6 million | - | 5.3 million |
2023-06-30 | 14.7 million | - | 5.5 million |
2023-03-31 | 13.8 million | - | 5.6 million |
2022-12-31 | 17.4 million | - | 5.8 million |
NBSE Shares Outstanding
NBSE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 387564 | 1.2 million | - |
2023-06-30 | 6 | 1.3 million | 2.4 million | - |
2023-03-31 | 13447 | 1.2 million | 2.9 million | - |
2022-12-31 | 49844 | 1.4 million | 2.6 million | - |
NBSE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 250246 |
2023-06-30 | - | 303975 |
2023-03-31 | - | 300473 |
2022-12-31 | - | - |
NBSE
Price: $0.40
52 week price:
Earnings Per Share: -18.60 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 97523
Market Capitalization: 1.5 million